- Continued progress on CBD patent formulas
- Update on the development of three CBD formulas already under the provisory patent
- Additional three products at various stages with Bionatus
Earth Science Tech, Inc. (OTC: ETST), a biotechnology company focused on cannabidiol (CBD), nutraceuticals, pharmaceuticals and medical devices, shared progress on its CBD patent formulas in a recent press release (http://nnw.fm/O6QyQ). The company has three new CBD formulas under the provisory patent and three Bionatus products in various stages of development.
ETST is developing three CBD formulas already under the provisory patent whose function is to maintain quality of life and prevent inflammation, cancer and degenerative diseases. The company announced in March (http://nnw.fm/QOd0b) that it had received a grant from the Government of Quebec earmarked for the pre-launch process of these three CBD-based nutraceutical provisional patent products.
Research and development has been very promising on the first two unique CBD formula products, a neuron protector and a breast protector. The final formulation is currently being developed to assure the longest possible shelf life using a yet to be determined natural protective agent. The third CBD formula is a unique superfood formulated from a mix of hemp oil and other vegetal oil(s), enriched with potent antioxidants and designed to improve antioxidant ingestion.
ETST has two products in development, Propovit and a reformulation of Bionatus, through a joint venture with Bionatus Laboratrio Botnico of Brazil and its Canadian division, Bionatus Botanical Laboratories, Inc. Propovit is used to help alleviate throat irritation, colds and bad breath. The new formulation will be enriched with ETST hemp oil. The main natural ingredient in Bionatus is the Guaco extract. Traditional uses of this extract suppose anti-inflammatory and bronchial-dilation properties, properties that ETST and Bionatus believe will be enriched with the addition of CBD. A third product is also being planned by ETST and Bionatus, with details to be shared soon.
The company intends to share further updates on its CBD IP patent formulas as they progress.
For more information, visit the company’s website at www.EarthScienceTech.com
More from NetworkNewsWire
About NetworkNewsWire
NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
For more information, please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
[email protected]